2 Results for "

PROTAC-mediated IRAK4 degradation

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "PROTAC-mediated IRAK4 degradation" in MCE Product Catalog:

Cat. No.: HY-174455
CAS No.: 3065494-66-5
Research Areas:  

Inflammation/Immunology

APH02174 is an orally effective and selective IRAK4 PROTAC degrader with a DC50 of 4.01 nM in THP-1 cells. APH02174 inhibits LPS (HY-D1056)-induced IL-6 release by degrading IRAK4 and blocking TLR/IL-1R downstream signaling. APH02174 exhibits favorable anti-inflammatory activity in both Imiquimod (HY-B0180)-induced psoriasis-like skin inflammation and collagen-induced arthritis models. APH02174 is useful for research on inflammatory diseases such as psoriasis and rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-174455A
Research Areas:  

Inflammation/Immunology

APH02174 hemiformic is an orally effective and selective IRAK4 PROTAC degrader with a DC50 of 4.01 nM in THP-1 cells. APH02174 hemiformic inhibits LPS (HY-D1056)-induced IL-6 release by degrading IRAK4 and blocking TLR/IL-1R downstream signaling. APH02174 hemiformic exhibits favorable anti-inflammatory activity in both Imiquimod (HY-B0180)-induced psoriasis-like skin inflammation and collagen-induced arthritis models. APH02174 hemiformic is useful for research on inflammatory diseases such as psoriasis and rheumatoid arthritis .
loading...
    loading...